Venaxis, Inc. (Nasdaq: APPY) provided an update on its clinical and commercial activities. The Company continues to enroll patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE